94518 ⎘
Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems; Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2 Nitrogen atoms
SUBSTITUTED QUINAZOLINES FOR INHIBITING KINASE ACTIVITY
#2NOVEL AMINO ACID DERIVATIVES
#3COMPOUNDS FOR PROLIFERATIVE DISORDERS
#4GCN2 MODULATOR COMPOUNDS
#54-SUBSTITUTED AMINOISOQUINOLINE DERIVATIVES
#6AROMATIC HETEROCYCLIC COMPOUND AND APPLICATION THEREOF
#7IRE1 SMALL MOLECULE INHIBITORS
#8GCN2 AND PERK KINASE INHIBITORS AND METHODS OF USE THEREOF
#9SUBSTITUTED QUINAZOLINES AS INHIBITORS OF KRAS G12C
#10COMPOUNDS WITH ARYLAMINE STRUCTURES
#11SUBSTITUTED QUINAZOLINES FOR INHIBITING KINASE ACTIVITY
#12Theramutein modultors
#13CDK2 INHIBITORS AND USES THEREOF
#14ARYL ETHER COMPOUNDS AS TEAD MODULATORS
#15INHIBITORS OF KRAS G12C
#16MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
#17Inhibitors of Glucose-6-phosphate Dehydrogenase and Uses Thereof
#18A PRECIPITATION PROCESS FOR AMORPHOUS LETERMOVIR
#19INHIBITORS OF KRAS G12C
#20IRE1 small molecule inhibitors
#21Sodium 2-[(4S)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4H-quinazolin-4-yl]acetate monohydrate, its preparation and use
#22A METHOD OF PRODUCING A CRYSTALLINE FORM OF SODIUM 2-[(4S)-8-FLUORO-2-[4-(3-METHOXYPHENYL)PIPERAZIN-1-YL]-3-[2-METHOXY-5-(TRIFLUOROMETHYL)PHENYL]-4H-QUINAZOLINE-4-YL]ACETATE TRIHYDRATE
#23Substituted piperazines as inhibitors of KRAS G12C
#24QUINAZOLINE COMPOUNDS AS INHIBITORS OF PREMATURE TERMINATION CODONS
#25Potassium salt of 2-[(4S)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4H-quinazolin-4-yl]acetic acid
#26COMPOUND AND COMPOSITION AS PDGF RECEPTOR KINASE INHIBITOR
#27Certain chemical entities, compositions, and methods
#28Quinazoline Compounds
#29INDENE DERIVATIVES USEFUL IN TREATING PAIN AND INFLAMMATION
#30Inhibitors of alpha 2 beta 1 integrin and methods of use thereof
#31Theramutein modulators
#32Theramutein modulators
#33Substituted quinazolines for inhibiting kinase activity
#34FGFR4 inhibitor, preparation method therefor and pharmaceutical use thereof
#35HETEROARYL COMPOUNDS AND USES THEREOF
#36Fused ring pyrimidine amino compound and preparation method, pharmaceutical composition, and use thereof
#37GCN2 and perk kinase inhibitors and methods of use thereof
#38IRE1 small molecule inhibitors
#39QUINAZOLINYL COMPOUNDS AND METHODS OF USE
#40INHIBITORS OF KRAS G12C
#41Modulators of RAS GTPase
#42TOLL LIKE RECEPTOR MODULATOR COMPOUNDS
#43Heteroaryl modulators of RAS GTPase
#44Small Molecule Modulators of RAS GTPase
#45PYRIMIDINE COMPOUNDS AND METHODS USING THE SAME
#46BETA-ADRENERGIC RECEPTOR ALLOSTERIC MODULATORS
#47INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR
#48IRE1 small molecule inhibitors
#49Compound for organic electric element, organic electric element comprising the same, and electronic device thereof
#504-SUBSTITUTED AMINOISOQUINOLINE DERIVATIVES
#51Substituted quinazolines as inhibitors of KRAS G12C
#52CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS
#53Indene derivatives useful in treating pain and inflammation
#54Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria
#55Certain chemical entities, compositions, and methods
#56Theramutein modulators
#57Theramutein modulators
#58IRE1 small molecule inhibitors
#59Quinazoline compounds
#60Substituted quinazolines for inhibiting kinase activity
#61Therapeutic compounds as inhibitors of the orexin-1 receptor
#62Small molecule BET bromodomain inhibitors and uses thereof
#63STK19 inhibitors for treatment of cancer
#64Certain chemical entities, compositions, and methods
#65IRE1 small molecule inhibitors
#66REMOVAL OF SENESCENCE-ASSOCIATED MACROPHAGES
#67Inhibitors of the fibroblast growth factor receptor
#68Substituted cinnolines as inhibitors of KRAS G12C
#69Methods for preparing substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine
#70COMPOUNDS WITH ARYLAMINE STRUCTURES
#71Theramutein modulators
#72Solid forms of substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds
#73Pyrimidine compounds and methods using the same
#74Heteroaryl compounds and uses thereof
#75INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR
#76Heterocyclic substituted 2-amino quinazoline derivatives for the treatment of viral infections
#77Substituted quinazolines for inhibiting kinase activity
#78TOLL LIKE RECEPTOR MODULATOR COMPOUNDS
#79FGFR4 inhibitor, preparation method therefor and pharmaceutical use thereof
#80Methods for preparing substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine
#81Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria
#824-substituted aminoisoquinoline derivatives
#83IRE1 small molecule inhibitors
#84Quinazoline compounds
#85Substituted carbonucleoside derivatives useful as anticancer agents
#86Inhibitors of the fibroblast growth factor receptor
#87IRE1 SMALL MOLECULE INHIBITORS
#88Processes for making substituted quinazoline compounds using hydrogen bonding catalysts
#89Bicyclic BET bromodomain inhibitors and uses thereof
#90Solid forms of substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds
#91Substituted quinazolines for inhibiting kinase activity
#92Substituted quinolines as inhibitors of KRAS G12C
#93Certain chemical entities, compositions, and methods
#94Methods for preparing substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine
#95Theramutein modulators
#96Aminoquinazoline compounds as Aantagonist
#97Heteroaryl compounds and uses thereof
#98Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria
#99Compositions and Methods for Treating Anxiety and Compulsive Behavior
#100Salts of a dihydroquinazoline derivative
#101Quinazoline compounds
#102Heterocyclic substituted 2-amino quinazoline derivatives for the treatment of viral infections
#103Substituted carbonucleoside derivatives useful as anticancer agents
#104Therapeutic compounds as inhibitors of the orexin-1 receptor
#105Toll like receptor modulator compounds
#106Inhibitors of the fibroblast growth factor receptor
#107Methods for preparing substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine
#108Solid forms of substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds
#1092-amino-5-keto-pyrimidine derivatives and the use thereof for controlling undesired plant growth
#110Salts of a dihydroquinazoline derivative
#111Pyrimidine compounds and methods using the same
#1123,4-dihydroquinazoline derivative and combination comprising the same
#113INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR
#114CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS
#115Process for making substituted quinazoline compounds
#116Certain chemical entities, compositions, and methods
#117Quinazoline compounds
#118Fused heterocyclic compound, preparation method therefor, pharmaceutical composition, and uses thereof
#119Heteroaryl compounds and uses thereof
#120Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria
#121Amorphous letermovir and solid pharmaceutical formulations thereof for oral administration
#122Fused pyrimidine compounds and use thereof
#1232 amino-3,4-dihydrcquinazoline derivatives and the use thereof as cathepsin D inhibitors
#124QUINOLINYL GLUCAGON RECEPTOR MODULATORS
#125Heterocyclic substituted 2-amino quinazoline derivatives for the treatment of viral infections
#126Substituted quinazolines as inhibitors of KRAS G12C
#127Inhibitors of the fibroblast growth factor receptor
#128Substituted quinazolines for inhibiting kinase activity
#129ALKYNYL HETEROAROMATIC COMPOUND AND USE THEREOF
#130Substituted quinazolines as kinase inhibitors
#131Pharmaceutical composition containing an antivirally active dihydroquinazoline derivative
#132Theramutein modulators
#133Inhibitors of the fibroblast growth factor receptor
#134Quinolinyl glucagon receptor modulators
#135Salts of a dihydroquinazoline derivative
#136Sodium and calcium salts of dihydroquinazoline derivative and use thereof as antiviral agents
#137Inhibitors of the fibroblast growth factor receptor
#138Heteroaryl compounds and uses thereof
#139Pyrene-based compound and organic light-emitting diode including the same
#140HETEROCYCLIC COMPOUNDS AND THEIR USE AS BINDING PARTNERS FOR 5-HT5 RECEPTORS
#141INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR
#142Production of dense bodies (DB) from HCMV-infected cells
#143Quinolinyl glucagon receptor modulators
#144Inhibitors of the fibroblast growth factor receptor
#145Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria
#146Aryl urea derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulators
#147Quinazoline compounds as sodium channel blockers
#148Inhibition of memapsin 1 cleavage in the treatment of diabetes
#149Amine-based compound, organic light-emitting diode including the same, and organic light-emitting apparatus including the amine-based compound
#150Heterocyclic derivative and pharmaceutical composition comprising the same
#151THERAMUTEIN MODULATORS
#152Aryl urea derivatives as N-formyl peptide receptors like-1 (FPRL-1) receptor modulators
#153HETEROCYCLIC COMPOUNDS, THEIR PREPARATION AND THERAPEUTIC APPLICATION
#154Process for the preparation of dihydroquinazolines
#155HSP90 inhibitors
#156Inhibitors of the hedgehog pathway
#157Quinazoline derivatives
#158Inhibitors of the hedgehog pathway
#159Compositions useful as inhibitors of protein kinases
#160HSP90 INHIBITORS
#161Process for the preparation of dihydroquinazolines
#162Pyrimidine derivative, preparation method and use thereof
#163SUBSTITUTED 2-AMINO-FUSED HETEROCYCLIC COMPOUNDS
#164Chemical inhibitors of ethylene biosynthesis
#165BICYCLIC COMPOUNDS AS INHIBITORS OF DIACYGLYCEROL ACYLTRANSFERASE
#166USE OF BUFFERS FOR RADIONUCLIDE COMPLEXATION
#167Bicyclic compounds as inhibitors of diacylglycerol acyltransferase
#168Substituted pyrimidine compounds as RAF inhibitors and methods of use
#169Quinazoline inhibitors of BACE 1 and methods of using
#170Methods of enhancing sweet taste of compositions using substituted thieno{2,3-D}pyrimidines
#171COMPOUNDS FOR THE TREATMENT AND PREVENTION OF INFLUENZA
#172CERTAIN CHEMICAL ENTITIES AND THERAPEUTIC USES THEREOF
#173Method for producing quinazoline derivative
#174SUBSTITUTED QUINAZOLINES
#175Quinazolin-oxime derivatives as Hsp90 inhibitors
#176SUBSTITUTED QUINAZOLINES
#177HSP90 INHIBITORS
#1782-AMINOQUINAZOLINE DERIVATIVE
#179Novel Compounds for Treatment of Cancer and Disorders Associated With Angiogenesis Function
#180Preparation for external use
#1812-AMINOQUINAZOLINE DERIVATIVE
#182Compositions useful as inhibitors of protein kinases
#183Fused heterocyclic compounds as inhibitors of potassium channel function
#184Substituted heterocyclic compounds
#185Quinazolinamide derivatives
#186QUINAZOLINES FOR PDK1 INHIBITION
#187Hybrid 2-aminotetralin and aryl-substituted piperazine compounds and their use in altering CNS activity
#188Novel compounds for treating proliferative diseases
#1893,4-dihydroquinazoline derivatives
#190QUINAZOLINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF THROMBOCYTHEMIA
#191Substituted 2-amino-fused heterocyclic compounds
#192Agent for inhibiting cytokinin signaling
#193Heterocyclic compounds and their use as binding partners for 5-HT receptors
#194Quinazolines and Related Heterocyclic Compounds, and Their Therapeutic Use
#195Processes for the preparation of alfuzosin
#196HSP90 inhibitors
#197Compounds and Methods of Identifying, Synthesizing, Optimizing and Profiling Protein Modulators
#1982,4-Substituted Quinazolines as Lipid Kinase Inhibitors
#199Fused hetrocyclic compounds
#200Macrocyclic pyrimidine derivatives
#201Process for the preparation of dihydroquinazolines
#202Substituted 5,6,7,8-Tetrahydro-pyrido[4,3-d]pyrimidine-2-yl Compounds and 5,6,7,8-Tetrahydro-quinazoline-2-yl Compounds
#203Compounds and methods of use
#2042-aminoquinazoline derivatives
#205Inhibitors of hedgehog pathway
#206Guanidine derivatives and their medical use
#207NOVEL COMPOUNDS FOR TREATMENT OF CANCER AND DISORDERS ASSOCIATED WITH ANGIOGENESIS FUNCTION
#208Crystals, amorphous substances or salts of methyl N-[3-(6,7-dimethoxy-2-methylaminoquinazolin-4-yl) phenyl] terephthalamic acid
#209Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
#210Thiazolo[5,4-B]pyridine glucokinase activators
#211Compounds including substituted thienopyrimidinone derivatives as ligands for modulating chemosensory receptors
#212Chemokine receptor modulators
#213Therameutin modulators
#2142-amino-4-phenylquinazoline derivatives and the use thereof as HSP90 modulators
#215Substituted quinazolines for reducing platelet count
#216Trifluoromethyl substituted benzamides as kinase inhibitors
#2174-(3-benzoylaminophenyl)-6,7-dimethoxy-2-methylaminoquinazoline derivatives
#218Substituted 5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine-2-yl compounds and 5,6,7,8-tetrahydroquinazoline-2-yl compounds
#219Hedgehog pathway antagonists
#2202-Amino Quinazoline Derivative
#221Substituted dihydroquinazolines
#222Substituted quinazolinamine compounds for the treatment of cancer
#223Substituted quinazoline compounds useful as p38 kinase inhibitors
#224Guanidine derivatives
#2252-(3-phenyl-2-piperazinyl-3,4-dihydroquinazolin-4-yl)acetic acids as antiviral agents, especially against cytomegaloviruses
#226Aryl nitrogen-containing bicyclic compounds and methods of use
#2272-Amino-quinazolin-5-ones
#2288-alkoxy or cycloalkoxy-4-methyl-3,4-dihydro-quinazolin-2-ylamines
#229(3,4-dihydro-quinazolin-2-yl)-(2-aryloxy-ethyl)-amine
#230Compounds and methods of use
#231Novel compounds for treatment of cancer and disorders associated with angiogenesis function
#232(3,4-dihydro-quinazolin-2-yl)-indan-1-yl-amines
#2332-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE)
#234Heteroaryl guanidines; inhibitors of viral replication
#2352-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE)
#236Quinazoline derivatives and their use in the treatment of thrombocythemia
#237Trifluoromethyl substituted benzamides as kinase inhibitors
#238Novel irreversible inhibitors of epidermal growth factor receptor tyrosine kinase and uses thereof for therapy and diagnosis
#239Hybrid 2-aminoterailin and aryl-substituted piperazine compounds and their use in altering CNS activity
#240Combi-molecules having EGFR and DNA targeting properties
#241Quinazolinyl compounds as inhibitors of potassium channel function
#242Fused heterocyclic compounds
#2433,4-dihydroquinazoline derivatives as T-type calcium channel blockers and method of preparing the same
#244Quinazoline derivatives and medicaments
#245Neuropeptide Y antagonists
#246Compositions useful as inhibitors of protein kinases
#2472-Guanidino-4-heterocyclylquinazolines
#248Novel norepinephrine reuptake inhibitors for the treatment of central nervous system disorders
#249Substituted dihydroquinazolines
#2504-Aryliquinazolines and the use thereof as nhe-3 inhibitors
#251Substituted heteroaryls